Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Currently, an increasing number of diseases related to insulin resistance and obesity is an alarming problem worldwide. It is well-known that the above states can lead to the development of type 2 diabetes, hypertension, and cardiovascular diseases. An excessive amount of triacylglycerols (TAGs) in...
Main Authors: | Patrycja Bielawiec, Ewa Harasim-Symbor, Adrian Chabowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00114/full |
Similar Items
-
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
by: Patrycja Bielawiec, et al.
Published: (2020-08-01) -
Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
by: Tomasz Charytoniuk, et al.
Published: (2022-02-01) -
Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
by: Klaudia Berk, et al.
Published: (2021-01-01) -
Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
by: Patrycja Bielawiec, et al.
Published: (2021-05-01) -
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
by: Alex Straiker, et al.
Published: (2021-09-01)